Skip to content

Virtual Reality System for Anxiety and OCD

Low-Cost, Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and Obsessive Compulsive Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03636022
Enrollment
45
Registered
2018-08-17
Start date
2020-11-01
Completion date
2023-05-31
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Obsessive-Compulsive Disorder

Keywords

Anxiety, OCD, Obsessive Compulsive Disorder, Generalized Anxiety Disorder, Social Phobia, Separation Anxiety, GAD, Youth, Teen, Therapy, Specific Phobia, Children

Brief summary

Cognitive Behavioral Therapy with fear provoking exposures is the most effective therapy for anxiety disorders. The investigators aim to enhance this therapy with the use of virtual reality exposures. The human subjects study will test the effects of using VR for exposures compared to traditional imaginal exposures on anxiety symptom improvement, functioning, child engagement in an response to exposures, completion of exposure homework between treatment sessions, and length of treatment in weeks and length of treatment among children with anxiety disorders and/or obsessive compulsive disorder. The funding award supports the development of the technology and the human subjects study. The subcontract to Mayo supports expert input to identify clinically relevant content for therapeutic videos on the VR system and the human subjects study to test the VR system.

Detailed description

Seventy children with childhood anxiety disorders (CADs) or obsessive compulsive disorder (OCD) and a parent will be recruited to test the Phase II VR system with a randomized controlled mixed methods study. Participants will be identified through the Mayo Clinic Pediatric Anxiety Disorders Clinic (PADC). Participants will be randomly assigned to home exposure practice with or without the VR system, i.e., intervention or control, respectively. All participants in the study will participate in an introductory session in which participants complete two exposures related to content from their fear ladder, one with the VR system and analogous imaginal exposure. Each family will receive instructions for how to use the Mayo Clinic Anxiety Coach tablet app to record exposures during home practice. Participants will then be assigned one week of daily exposure homework for the intervention and control conditions. Participants randomized to the intervention condition will take home the VR system for homework completion and participants assigned to control will be instructed to complete imaginal exposures. One week after the introductory session, all participants will return for a session in which participants complete both types of exposure. Participants will also be assigned to a third generalization exposure, i.e., an exposure related to the baseline exposure that is higher on the fear ladder, to complete at their next anxiety clinic treatment sessions. SUDS ratings for each type of exposure will be recorded electronically via the Mayo Clinic Anxiety Coach. During the follow up session, an independent interviewer will observe participants' engagement during exposure and will interview participants and their parents about their experience with both types of exposure.

Interventions

OTHERVR System

Use of virtual reality to deliver exposure therapy

OTHERControl

Use of conventional delivery of exposure therapy

Sponsors

Mayo Clinic
CollaboratorOTHER
Minnesota HealthSolutions
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants will be randomly assigned to home exposure practice with or without the VR system, i.e., intervention or control

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age 7 to 17 2. Primary diagnosis of an anxiety disorder or obsessive compulsive disorder.

Exclusion criteria

1. History of and/or current diagnosis of: psychosis, autism, bipolar disorder, mental retardation, oppositional defiant disorder, PTSD, selective mutism or major depressive disorder. 2. Current sucidality or recent suicidal behavior. 3. Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties. 4. Starting or changing the dosage of psychiatric medications in the last 2 months.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session 1Baseline and End of Session I, 2 hoursThe SUDS - 0 to 10 ratings, where 0 indicates that participants feel no anxiety at all and 10 indicates that participants are experiencing maximum distress. The mean change in SUDS during the Session VR exposure versus mean change in SUDS during the conventional (control condition) verbal imaginal exposure.
Maximum SUDS Rating During Crossover Exposure2 hoursCrossover exposure refers to the Session 2 virtual reality exposure for the control group and to the Session 2 imaginal exposure for the virtual reality group. The SUDs Rating Scale, or Subjective Units of Distress Scale (SUDs) is used to measure the intensity of distress or anxiety. The SUDs is a self-assessment tool rated on a scale from 0 to 10. Ten represents the highest level of distress and 0 represents no distress.

Secondary

MeasureTime frameDescription
Homework Engagement1 weekNumber of homework exposures completed.

Countries

United States

Participant flow

Participants by arm

ArmCount
VR System
Participants will then be assigned one week of daily exposure homework. Patients randomized to the intervention condition will take home the VR system for homework. VR System: Use of virtual reality to deliver exposure therapy
25
Control Condition
Participants will then be assigned one week of daily exposure homework. Participants assigned to control will be instructed to complete imaginal exposures. Control: Use of conventional delivery of exposure therapy
20
Total45

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject13

Baseline characteristics

CharacteristicVR SystemControl ConditionTotal
Age, Continuous13.3 years
STANDARD_DEVIATION 2.6
13.1 years
STANDARD_DEVIATION 3
13.2 years
STANDARD_DEVIATION 2.8
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants20 Participants44 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Race
Asian
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Race
Black
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Race
Other
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Race
White
22 Participants18 Participants40 Participants
Region of Enrollment
United States
25 participants20 participants45 participants
Sex/Gender, Customized
Gender at Birth
Female
21 Participants17 Participants38 Participants
Sex/Gender, Customized
Gender at Birth
Male
4 Participants3 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 250 / 20
other
Total, other adverse events
0 / 250 / 20
serious
Total, serious adverse events
0 / 250 / 20

Outcome results

Primary

Maximum SUDS Rating During Crossover Exposure

Crossover exposure refers to the Session 2 virtual reality exposure for the control group and to the Session 2 imaginal exposure for the virtual reality group. The SUDs Rating Scale, or Subjective Units of Distress Scale (SUDs) is used to measure the intensity of distress or anxiety. The SUDs is a self-assessment tool rated on a scale from 0 to 10. Ten represents the highest level of distress and 0 represents no distress.

Time frame: 2 hours

ArmMeasureValue (MEAN)Dispersion
VR SystemMaximum SUDS Rating During Crossover Exposure2.1 units on a scaleStandard Deviation 2.3
Control ConditionMaximum SUDS Rating During Crossover Exposure2.5 units on a scaleStandard Deviation 1.8
Primary

Mean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session 1

The SUDS - 0 to 10 ratings, where 0 indicates that participants feel no anxiety at all and 10 indicates that participants are experiencing maximum distress. The mean change in SUDS during the Session VR exposure versus mean change in SUDS during the conventional (control condition) verbal imaginal exposure.

Time frame: Baseline and End of Session I, 2 hours

ArmMeasureValue (MEAN)Dispersion
VR SystemMean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session 1-3.7 units on a scaleStandard Deviation 2
Control ConditionMean Change From Baseline in Subjective Units of Distress Scale (SUDS) at End of Session 1-3.6 units on a scaleStandard Deviation 1.9
Secondary

Homework Engagement

Number of homework exposures completed.

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
VR SystemHomework Engagement5.4 homework exposures completedStandard Deviation 1.5
Control ConditionHomework Engagement5.9 homework exposures completedStandard Deviation 1.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026